- Home
- MBC vs SANA Comparison
MBC vs SANA Comparison
Compare MBC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBC | SANA |
|---|---|---|
| Founded | 1954 | 2018 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MBC | SANA |
|---|---|---|
| Price | $11.65 | $3.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $15.00 | $7.83 |
| AVG Volume (30 Days) | 2.1M | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.45 | N/A |
| P/E Ratio | $55.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.33 | $1.26 |
| 52 Week High | $16.86 | $6.55 |
Technical Indicators
Market Signals| Indicator | MBC | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 40.15 |
| Support Level | $11.50 | $3.53 |
| Resistance Level | $12.40 | $3.98 |
| Average True Range (ATR) | 0.59 | 0.29 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 20.24 | 20.81 |
Price Performance
Historical ComparisonAbout MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.